您当前所在位置:首页 > 资讯信息 > 新品上市
序号 标题 次数 作者 发布时间
74071 cas:330970-70-2 Alloc-Val-Ala-OH 83 zyl 2024-12-19
74072 DOTA-somatostatin receptor analogs DOTA生长抑素受体类似物 68 h 2024-12-19
74073 CAS: 2754384-60-4,DBCO-(PEG)3-VC-PAB-MMAE 69 WYQ 2024-12-19
74074 Fmoc-Gln(Trt)-PAB-OH, ADC试剂 111 kx 2024-12-19
74075 CAS: 2994332-18-0 ,DBCO-C4-Val-Cit-PABC-PNP,二苯并环辛炔-C4-缬氨酸-瓜氨酸-PABC-对硝基苯基磷酸酯 79 WYQ 2024-12-19
74076 cas:159857-60-0,Fmoc-Lys(MMt)-OH,N-[(9H-芴-9-基甲氧基)羰基]-N'-[(4-甲氧基苯基)二苯基甲基]-L-赖氨酸 166 kx 2024-12-19
74077 DBCO-PEG3-Val-Cit-PAB-PNP,二苯并环辛炔-三聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP 112 WYQ 2024-12-19
74078 NOTA-anti-HER2 NOTA标记抗人表皮生长因子受体2型(HER2)纳米体 110 h 2024-12-19
74079 cas:186023-44-9 Fmoc-Ala-Pro-OH 97 zyl 2024-12-19
74080 TCO-PEG4-Val-Cit-PAB-PNP,反式环辛烯-四聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP 81 WYQ 2024-12-19
74081 Boc-Val-Cit CAS:870487-08-4 96 zyl 2024-12-19
74082 DOTA-Bn-FGK-Fab DOTA标记抗体片段 104 h 2024-12-19
74083 cas:252554-78-2,Fmoc-Ala-Ser (Psi(Me,Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 60 kx 2024-12-19
74084 DOTA-Nal3-Octreotide DOTANOC DOTA-Nal3-奥曲肽 97 h 2024-12-19
74085 cas:2413428-36-9,MC-Gly-Gly-Phe-Gly,(S)-5-苄基-18-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-4,7,10,13-四氧代-3,6,9,12-四氮杂十八烷-1-酸 80 kx 2024-12-19
74086 MC-Val-Cit-PAB-PNP CAS:159857-81-5 123 zyl 2024-12-19
74087 cas:2353409-52-4,Mal-amido-PEG8-Val-Gly-PAB-OH,马来酰亚胺-酰胺-八聚乙二醇-VAL-GLY-PAB-羟基 70 kx 2024-12-19
74088 Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB CAS:2055042-69-6 72 zyl 2024-12-19
74089 cas:1895916-22-9,MC-Val-Ala-OH, ADC试剂 70 kx 2024-12-19
74090 cas:159857-70-2,MC-Val-Cit-Doxorubicin,MC-VAL-CIT-阿霉素 63 kx 2024-12-19
74091 DOTA−Gal-NAPamide DOTA−Gal-纳帕胺 71 h 2024-12-19
74092 DOTA-peptide-Lym-1 radioimmunotherapy DOTA-肽-Lym-1 82 h 2024-12-19
74093 N-DBCO-N-bis(PEG2-amide-PEG4-Val-cit-PAB-MMAE), N-二苯并环辛炔-N-双(二聚乙二醇-酰胺-四聚乙二醇-VAL-CIT-PAB-MMAE) 95 kx 2024-12-19
74094 DOTA-dGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 104 h 2024-12-19
74095 DOTA-MGO DOTA-DGlu-(Glu)s-minigastrin 76 h 2024-12-19
74096 cas:2762518-86-3,NHS Ester-PEG4-Val-Cit-PAB-MMAE, ADC试剂 126 kx 2024-12-19
74097 DOTA-scFv-anti-PSMA DOTA-scFv-抗PSMA脂质纳米粒(LNPs) 77 h 2024-12-19
74098 cas:2353409-45-5,BCN-PEG3-Val-Cit-PFP Ester, ADC试剂 70 kx 2024-12-19
74099 cas:2112738-13-1,Mal-amido-PEG2-Val-Cit-PAB-PNP, ADC试剂 76 kx 2024-12-19
74100 cas:2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH, ADC试剂 70 kx 2024-12-19
74101 cas:2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH, ADC试剂 124 kx 2024-12-19
74102 Fmoc-PEG3-Val-Cit,N-芴甲氧羰基-三聚乙二醇-VAL-CIT 97 kx 2024-12-19
74103 DOTA-anti-VLA-4 79 h 2024-12-19
74104 DOTA-glycylglycylglycyl-l-p-isothiocyanatophenylalanine amide 81 h 2024-12-19
74105 CAS: 2748039-76-9, Alkyne-Val-Cit-PAB-FAM,炔-Val-Cit-PAB-FAM 72 WYQ 2024-12-19
74106 CAS:646502-53-6 MC-Val-Cit-PAB-MMAE的结构式 107 zyl 2024-12-19
74107 Amino-PEG2-VG-N-Bis(PEG1-azide),氨基-二聚乙二醇-VG-N-双(一聚乙二醇-叠氮) 88 WYQ 2024-12-19
74108 Azido-PEG8-Val-Cit-PAB-PNP,C34H47N9O12 91 WYQ 2024-12-19
74109 化合物:TCO-MMAE,反式环辛烯-MMAE(其中MMAE为单甲基澳瑞他汀E的缩写) 132 WYQ 2024-12-19
74110 cas:2748039-77-0,Alkyne-Val-Cit-PAB-PNP,炔-VAL-CIT-PAB-PNP 酯 86 kx 2024-12-19
74111 endo BCN-PEG3-Val-Cit,endo BCN-聚乙二醇3-缬氨酸-瓜氨酸,CAS号:1263166-91-1 111 WYQ 2024-12-19
74112 cas:1803279-86-8,DBCO-C4-SulfoNHS ester, ADC试剂 72 kx 2024-12-19
74113 Mal-PEG8-Val-Cit-PAB-MMAE CAS:2353409-69-3 83 zyl 2024-12-19
74114 159857-80-4,MC-Val-Cit-PAB-OH,MC-VAL-CIT-PAB中间体 77 kx 2024-12-19
74115 氨基-四聚乙二醇-Val-Cit-PAB-MMAE,Amino-PEG4-Val-Cit-PAB-MMAE,ADC定制 57 wyh 2024-12-19
库存查询